These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25376281)

  • 21. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N; Yamamoto H; Sasaki S; Itoh F; Suzuki H; Kikuchi T; Kaneto H; Iku S; Ozeki I; Karino Y; Satoh T; Toyota J; Satoh M; Endo T; Imai K
    Oncogene; 2000 Nov; 19(46):5298-302. PubMed ID: 11077447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent concomitant epigenetic silencing of SOX1 and secreted frizzled-related proteins (SFRPs) in human hepatocellular carcinoma.
    Shih YL; Hsieh CB; Yan MD; Tsao CM; Hsieh TY; Liu CH; Lin YW
    J Gastroenterol Hepatol; 2013 Mar; 28(3):551-9. PubMed ID: 23215838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylation profiling of tumor suppressor genes and oncogenes in hepatitis virus-related hepatocellular carcinoma in northern India.
    Kiran M; Chawla YK; Kaur J
    Cancer Genet Cytogenet; 2009 Dec; 195(2):112-9. PubMed ID: 19963110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M
    Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation profiling identifies EYA4 gene as a prognostic molecular marker in hepatocellular carcinoma.
    Hou X; Peng JX; Hao XY; Cai JP; Liang LJ; Zhai JM; Zhang KS; Lai JM; Yin XY
    Ann Surg Oncol; 2014 Nov; 21(12):3891-9. PubMed ID: 24306662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L
    Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p16 promoter hypermethylation in human hepatocellular carcinoma with or without hepatitis virus infection.
    Narimatsu T; Tamori A; Koh N; Kubo S; Hirohashi K; Yano Y; Arakawa T; Otani S; Nishiguchi S
    Intervirology; 2004; 47(1):26-31. PubMed ID: 15044833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma.
    Roncalli M; Bianchi P; Bruni B; Laghi L; Destro A; Di Gioia S; Gennari L; Tommasini M; Malesci A; Coggi G
    Hepatology; 2002 Aug; 36(2):427-32. PubMed ID: 12143052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CpG Methylation Signature Predicts Recurrence in Early-Stage Hepatocellular Carcinoma: Results From a Multicenter Study.
    Qiu J; Peng B; Tang Y; Qian Y; Guo P; Li M; Luo J; Chen B; Tang H; Lu C; Cai M; Ke Z; He W; Zheng Y; Xie D; Li B; Yuan Y
    J Clin Oncol; 2017 Mar; 35(7):734-742. PubMed ID: 28068175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation.
    Oh BK; Kim H; Park HJ; Shim YH; Choi J; Park C; Park YN
    Int J Mol Med; 2007 Jul; 20(1):65-73. PubMed ID: 17549390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas].
    Wang JH; Qin Y; Li B; Sun ZL; Sun ZF; Guan QL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):686-8. PubMed ID: 16235538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.
    Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ
    Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Screening for differential methylation status by CpG island microarray in the hepatocellular carcinoma cell lines].
    Zheng D; Liu BB; Liu YK; Kang XN; Sun L; Guo K; Sun RX; Chen J; Zhao Y
    Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):891-6. PubMed ID: 19173987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
    Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
    Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
    Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.
    Shitani M; Sasaki S; Akutsu N; Takagi H; Suzuki H; Nojima M; Yamamoto H; Tokino T; Hirata K; Imai K; Toyota M; Shinomura Y
    Tumour Biol; 2012 Oct; 33(5):1307-17. PubMed ID: 22457049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma.
    Villanueva A; Portela A; Sayols S; Battiston C; Hoshida Y; Méndez-González J; Imbeaud S; Letouzé E; Hernandez-Gea V; Cornella H; Pinyol R; Solé M; Fuster J; Zucman-Rossi J; Mazzaferro V; Esteller M; Llovet JM;
    Hepatology; 2015 Jun; 61(6):1945-56. PubMed ID: 25645722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ; Wang L; Wang JP; Li JQ; Zhang CQ; Zheng L; Yuan YF
    Ai Zheng; 2006 Jun; 25(6):696-700. PubMed ID: 16764763
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-wide discovery and validation of diagnostic DNA methylation-based biomarkers for hepatocellular cancer detection in circulating cell free DNA.
    Hlady RA; Zhao X; Pan X; Yang JD; Ahmed F; Antwi SO; Giama NH; Patel T; Roberts LR; Liu C; Robertson KD
    Theranostics; 2019; 9(24):7239-7250. PubMed ID: 31695765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.